SummitTX Capital’s Replimune Group REPL Stock Holding History

SummitTX Capital’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-288,889	Closed	-$2.21M	–	983
2026 Q1	$2.21M	Buy	288,889 +180,086	+166%	+$1.38M	0.07%	291
2025 Q4	$1.06M	Buy	+108,803	New	+$925K	0.03%	408
2025 Q3	–	Sell	-69,202	Closed	-$643K	–	944
2025 Q2	$643K	Sell	69,202 -39,869	-37%	-$348K	0.03%	461
2025 Q1	$1.06M	Buy	+109,071	New	+$1.35M	0.05%	392

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

SummitTX Capital's REPL Position: Q2 2026 in Review

SummitTX Capital sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 288,889 shares — an estimated $2.21M sold.

SummitTX Capital first reported a position in REPL in Q1 2025 and held it in 4 quarters. The position peaked at $2.21M in Q1 2026. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

SummitTX Capital reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
SummitTX Capital sold 288,889 Replimune Group shares in Q2 2026, an estimated $2.21M.
SummitTX Capital first reported a position in Replimune Group in Q1 2025 and held it in 4 quarters.
SummitTX Capital's Replimune Group position peaked at $2.21M in Q1 2026.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.